These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 22037410

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The novel adenosine A(2A) antagonist prodrug MSX-4 is effective in animal models related to motivational and motor functions.
    Santerre JL, Nunes EJ, Kovner R, Leser CE, Randall PA, Collins-Praino LE, Lopez Cruz L, Correa M, Baqi Y, Müller CE, Salamone JD.
    Pharmacol Biochem Behav; 2012 Oct; 102(4):477-87. PubMed ID: 22705392
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Differential effects of adenosine antagonists in two models of parkinsonian tremor.
    Trevitt J, Kawa K, Jalali A, Larsen C.
    Pharmacol Biochem Behav; 2009 Nov; 94(1):24-9. PubMed ID: 19602422
    [Abstract] [Full Text] [Related]

  • 6. The non-selective adenosine antagonist theophylline reverses the effects of dopamine antagonism on tremor, motor activity and effort-based decision-making.
    Pardo M, Paul NE, Collins-Praino LE, Salamone JD, Correa M.
    Pharmacol Biochem Behav; 2020 Nov; 198():173035. PubMed ID: 32910928
    [Abstract] [Full Text] [Related]

  • 7. Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptors.
    Farrar AM, Segovia KN, Randall PA, Nunes EJ, Collins LE, Stopper CM, Port RG, Hockemeyer J, Müller CE, Correa M, Salamone JD.
    Neuroscience; 2010 Apr 14; 166(4):1056-67. PubMed ID: 20096336
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Adenosine A2A receptor antagonism and genetic deletion attenuate the effects of dopamine D2 antagonism on effort-based decision making in mice.
    Pardo M, Lopez-Cruz L, Valverde O, Ledent C, Baqi Y, Müller CE, Salamone JD, Correa M.
    Neuropharmacology; 2012 Apr 14; 62(5-6):2068-77. PubMed ID: 22261384
    [Abstract] [Full Text] [Related]

  • 10. Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism.
    Salamone JD, Farrar AM, Font L, Patel V, Schlar DE, Nunes EJ, Collins LE, Sager TN.
    Behav Brain Res; 2009 Jul 19; 201(1):216-22. PubMed ID: 19428636
    [Abstract] [Full Text] [Related]

  • 11. Tremorolytic effects of adenosine A2A antagonists: implications for parkinsonism.
    Salamone JD, Betz AJ, Ishiwari K, Felsted J, Madson L, Mirante B, Clark K, Font L, Korbey S, Sager TN, Hockemeyer J, Muller CE.
    Front Biosci; 2008 May 01; 13():3594-605. PubMed ID: 18508458
    [Abstract] [Full Text] [Related]

  • 12. Effects of the selective adenosine A2A receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark mice.
    Smith KM, Browne SE, Jayaraman S, Bleickardt CJ, Hodge LM, Lis E, Yao L, Rittle SL, Innocent N, Mullins DE, Boykow G, Reynolds IJ, Hill D, Parker EM, Hodgson RA.
    Eur J Pharmacol; 2014 Apr 05; 728():31-8. PubMed ID: 24486705
    [Abstract] [Full Text] [Related]

  • 13. The adenosine A2A antagonist KF17837 reverses the locomotor suppression and tremulous jaw movements induced by haloperidol in rats: possible relevance to parkinsonism.
    Correa M, Wisniecki A, Betz A, Dobson DR, O'Neill MF, O'Neill MJ, Salamone JD.
    Behav Brain Res; 2004 Jan 05; 148(1-2):47-54. PubMed ID: 14684247
    [Abstract] [Full Text] [Related]

  • 14. Deep brain stimulation of the subthalamic nucleus reverses oral tremor in pharmacological models of parkinsonism: interaction with the effects of adenosine A2A antagonism.
    Collins-Praino LE, Paul NE, Ledgard F, Podurgiel SJ, Kovner R, Baqi Y, Müller CE, Senatus PB, Salamone JD.
    Eur J Neurosci; 2013 Jul 05; 38(1):2183-91. PubMed ID: 23600953
    [Abstract] [Full Text] [Related]

  • 15. Effect of subtype-selective adenosine receptor antagonists on basal or haloperidol-regulated striatal function: studies of exploratory locomotion and c-Fos immunoreactivity in outbred and A(2A)R KO mice.
    Pardo M, López-Cruz L, Valverde O, Ledent C, Baqi Y, Müller CE, Salamone JD, Correa M.
    Behav Brain Res; 2013 Jun 15; 247():217-26. PubMed ID: 23557694
    [Abstract] [Full Text] [Related]

  • 16. Discovery of phosphoric acid mono-{2-[(E/Z)-4-(3,3-dimethyl-butyrylamino)-3,5-difluoro-benzoylimino]-thiazol-3-ylmethyl} ester (Lu AA47070): a phosphonooxymethylene prodrug of a potent and selective hA(2A) receptor antagonist.
    Sams AG, Mikkelsen GK, Larsen M, Langgård M, Howells ME, Schrøder TJ, Brennum LT, Torup L, Jørgensen EB, Bundgaard C, Kreilgård M, Bang-Andersen B.
    J Med Chem; 2011 Feb 10; 54(3):751-64. PubMed ID: 21210664
    [Abstract] [Full Text] [Related]

  • 17. The adenosine A2A antagonist MSX-3 reverses the effort-related effects of dopamine blockade: differential interaction with D1 and D2 family antagonists.
    Worden LT, Shahriari M, Farrar AM, Sink KS, Hockemeyer J, Müller CE, Salamone JD.
    Psychopharmacology (Berl); 2009 Apr 10; 203(3):489-99. PubMed ID: 19048234
    [Abstract] [Full Text] [Related]

  • 18. The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor.
    Podurgiel SJ, Nunes EJ, Yohn SE, Barber J, Thompson A, Milligan M, Lee CA, López-Cruz L, Pardo M, Valverde O, Lendent C, Baqi Y, Müller CE, Correa M, Salamone JD.
    Neuroscience; 2013 Oct 10; 250():507-19. PubMed ID: 23867769
    [Abstract] [Full Text] [Related]

  • 19. CSC counteracts l-DOPA-induced overactivity of the corticostriatal synaptic ultrastructure and function in 6-OHDA-lesioned rats.
    Huang YX, Luo WF, Li D, Hu WD, Liu CF.
    Brain Res; 2011 Feb 28; 1376():113-21. PubMed ID: 21195062
    [Abstract] [Full Text] [Related]

  • 20. Tremorolytic effects of safinamide in animal models of drug-induced parkinsonian tremor.
    Podurgiel S, Collins-Praino LE, Yohn S, Randall PA, Roach A, Lobianco C, Salamone JD.
    Pharmacol Biochem Behav; 2013 Apr 28; 105():105-11. PubMed ID: 23360954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.